Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Phase 3
269
about 3.6 years
18+
256 sites in AR, AZ, CA +34
What this study is about
This trial is testing whether a longer duration of radiation therapy (fractionated stereotactic radiosurgery) is more effective than usual radiation therapy (stereotactic radiosurgery) for treating cancer that has spread to the brain. The goal is to determine if this new approach can improve outcomes for patients with this type of cancer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Fractionated Stereotactic Radiation Therapy
- 2.Receive Stereotactic Radiosurgery
- 3.Undergo Computed Tomography
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Incidence of adverse events (AEs), Intracranial progression-free survival (IPFS), Overall survival
imaging, radiation
Oncology